Stay updated with breaking news from Upright Technologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, today reported financial results for the fourth...
The agreement also allows the companies to develop new or improved tools for Dario's chronic condition management platform.
Sanofi and digital therapeutics company DarioHealth will work together to promote the tech firm’s offerings for the management of chronic diseases. Under the $30 million, multi-year agreement, the partners will also develop new technology tools.
SWORD raised $163 million in Series D funding, which allowed for a secondary round where it scooped up another $26 million.
Chronic care management company DarioHealth scooped up digital mental health company wayForward for $30 million. While DarioHealth got its start in diabetes management, it has quickly been expanding its chronic care coverage to include mental health, hypertension and other conditions. As part of the acquisition, DarioHealth will be purchasing the creator of wayForward, PsyInnovations. The platform includes an artificial intelligence triage and screening tool that can help members find specific interventions. Patients are able to tap into cognitive behavioral therapy (CBT), self-directed care...